New inhaled therapy for stubborn lung infection shows promise in Late-Stage trial
Disease control
Terminated
This study tested whether adding an inhaled form of the drug clofazimine to standard treatment helps clear a stubborn lung infection called MAC (nontuberculous mycobacteria) in adults. The trial enrolled 132 people with MAC lung disease that did not improve with usual therapy. Th…
Phase: PHASE3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated May 02, 2026 23:35 UTC